Campbell Tiley

1.1k total citations
25 papers, 351 citations indexed

About

Campbell Tiley is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Campbell Tiley has authored 25 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Campbell Tiley's work include Multiple Myeloma Research and Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Campbell Tiley is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Campbell Tiley collaborates with scholars based in Australia, United Kingdom and United States. Campbell Tiley's co-authors include R Powles, S Milan, E. C. Gordon‐Smith, J. Treleaven, C. W. Smith, T J McElwain, Samuel T. Milliken, Ian Kerridge, Judith Trotman and Yiu Lam Kwan and has published in prestigious journals such as The Lancet, Blood and Cancer.

In The Last Decade

Campbell Tiley

23 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Campbell Tiley Australia 10 216 159 78 40 39 25 351
Maxim Norkin United States 12 231 1.1× 148 0.9× 86 1.1× 41 1.0× 45 1.2× 35 396
A.K. Burnett United Kingdom 11 327 1.5× 127 0.8× 95 1.2× 101 2.5× 56 1.4× 22 449
T Ninomiya Japan 9 213 1.0× 107 0.7× 46 0.6× 48 1.2× 52 1.3× 30 319
Gail Abrahamson United Kingdom 9 260 1.2× 87 0.5× 66 0.8× 33 0.8× 20 0.5× 13 346
Sanjeevan Sharma India 11 216 1.0× 59 0.4× 96 1.2× 32 0.8× 23 0.6× 53 306
Iolanda Donatella Vincelli Italy 11 227 1.1× 145 0.9× 122 1.6× 30 0.8× 28 0.7× 35 330
Min Ruan China 8 185 0.9× 71 0.4× 96 1.2× 86 2.1× 49 1.3× 66 303
Brigitte Witz France 8 203 0.9× 257 1.6× 101 1.3× 116 2.9× 76 1.9× 17 399
P. Dias Wickramanayake Germany 10 160 0.7× 149 0.9× 60 0.8× 44 1.1× 29 0.7× 22 400
Luz Tarín‐Arzaga Mexico 10 316 1.5× 69 0.4× 40 0.5× 55 1.4× 24 0.6× 34 405

Countries citing papers authored by Campbell Tiley

Since Specialization
Citations

This map shows the geographic impact of Campbell Tiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Campbell Tiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Campbell Tiley more than expected).

Fields of papers citing papers by Campbell Tiley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Campbell Tiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Campbell Tiley. The network helps show where Campbell Tiley may publish in the future.

Co-authorship network of co-authors of Campbell Tiley

This figure shows the co-authorship network connecting the top 25 collaborators of Campbell Tiley. A scholar is included among the top collaborators of Campbell Tiley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Campbell Tiley. Campbell Tiley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Odutola, Michael K., Marina T. van Leeuwen, Fiona Bruinsma, et al.. (2023). Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case–control study. Occupational and Environmental Medicine. 80(10). 599–602.
2.
Odutola, Michael K., Marina T. van Leeuwen, Julie K. Bassett, et al.. (2023). Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study. Frontiers in Nutrition. 9. 1048301–1048301.
3.
Odutola, Michael K., Marina T. van Leeuwen, Fiona Bruinsma, et al.. (2023). A Population-Based Family Case–Control Study of Sun Exposure and Follicular Lymphoma Risk. Cancer Epidemiology Biomarkers & Prevention. 33(1). 106–116. 1 indexed citations
4.
Odutola, Michael K., Marina T. van Leeuwen, Jennifer Turner, et al.. (2022). Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study. Cancer Epidemiology. 80. 102241–102241. 2 indexed citations
5.
Odutola, Michael K., Marina T. van Leeuwen, Jennifer Turner, et al.. (2022). Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia. Cancers. 14(11). 2710–2710. 8 indexed citations
6.
Stevenson, William, Jamie Bryant, Rob Sanson‐Fisher, et al.. (2019). A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons. Journal of Psychosocial Oncology. 38(3). 272–292. 22 indexed citations
7.
Nath, Christa E., Judith Trotman, Campbell Tiley, et al.. (2016). High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation. British Journal of Clinical Pharmacology. 82(1). 149–159. 41 indexed citations
8.
Lynagh, Marita, Tara Clinton‐McHarg, Alix Hall, et al.. (2015). Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Experimental Hematology and Oncology. 4(1). 15–15. 4 indexed citations
9.
Trotman, Judith, Peter J. Shaw, Campbell Tiley, et al.. (2015). Evaluation of Pharmacokinetic-Based Dose Predictions of High Dose Melphalan in Patients with Myeloma. Blood. 126(23). 4314–4314. 2 indexed citations
10.
11.
Mollee, Peter, Campbell Tiley, Ilona Cunningham, et al.. (2011). A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,. Blood. 118(21). 3973–3973. 3 indexed citations
12.
Nath, Christa E., Peter J. Shaw, Judith Trotman, et al.. (2010). Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. British Journal of Clinical Pharmacology. 69(5). 484–497. 57 indexed citations
13.
Murray, Patricia, Ian Kerridge, Campbell Tiley, et al.. (2009). Enrolment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement. Internal Medicine Journal. 40(2). 133–138. 5 indexed citations
14.
Trotman, Judith, Yiu Lam Kwan, Campbell Tiley, et al.. (2008). Consensus guidelines for ‘rainy day’ autologous stem cell harvests in New South Wales. Internal Medicine Journal. 38(4). 229–234. 1 indexed citations
15.
Favaloro, Emmanuel J., et al.. (1999). A Novel Factor V Null Mutation at Arg 506 Causes a False Positive Factor V Leiden Result. Thrombosis and Haemostasis. 82(9). 1198–1199. 9 indexed citations
16.
Tiley, Campbell, R Powles, J Treleaven, et al.. (1993). Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia.. PubMed. 12(5). 449–55. 12 indexed citations
17.
18.
Tiley, Campbell, Michael Findlay, J Treleaven, et al.. (1992). Tumour Lysis Following Hydrocortisone Prior to a Blood Product Transfusion in T-Cell Acute Lymphoblastic Leukaemia. Leukemia & lymphoma. 8(1-2). 143–146. 13 indexed citations
19.
Powles, R, C. W. Smith, J. Treleaven, et al.. (1990). Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial. The Lancet. 336(8728). 1417–1420. 103 indexed citations
20.
White, Les, Michelle Haber, Murray D. Norris, et al.. (1989). Therapy-induced drug resistance in a human leukemia line (LALW-2). Cancer. 63(11). 2103–2110. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maxim Norkin Breakdown of academic impact, for papers by A.K. Burnett Breakdown of academic impact, for papers by T Ninomiya Breakdown of academic impact, for papers by Gail Abrahamson Breakdown of academic impact, for papers by Sanjeevan Sharma Breakdown of academic impact, for papers by Iolanda Donatella Vincelli Breakdown of academic impact, for papers by Min Ruan Breakdown of academic impact, for papers by Brigitte Witz Breakdown of academic impact, for papers by P. Dias Wickramanayake Breakdown of academic impact, for papers by Luz Tarín‐Arzaga
Rankless by CCL
2026